Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Rosen

Showing results (51-60 of 149) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|April 15, 2008
Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1Ian Harley, Barry Rosen, Harvey A Risch, et al.
British Journal of Cancer|February 17, 2017
Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancerShana J Kim, Barry Rosen, Isabel Fan, et al.
Gynecologic Oncology|July 16, 2014
The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancerBarry Rosen, Stephane Laframboise, Sarah Ferguson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2Mario E Beiner, Barry Rosen, Anthony Fyles, et al.
Gynecologic Oncology|November 12, 2015
Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation statusJoanne Kotsopoulos, Barry Rosen, Isabel Fan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2014
Telomere length and mortality following a diagnosis of ovarian cancerJoanne Kotsopoulos, Jennifer Prescott, Immaculata De Vivo, et al.
Gynecologic Oncology|December 21, 2012
Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profilesTaymaa May, Melina Shoni, Christopher P Crum, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Role of adjuvant radiotherapy in granulosa cell tumors of the ovaryJan Hauspy, Mario E Beiner, Ian Harley, et al.
Ecancermedicalscience|October 18, 2024
'Addressing HPV vaccine hesitancy: unveiling concerns and building trust' perspectives of adolescent girls and parents in Kisumu County, KenyaEdwin Onyango Ochomo, Philiph Tonui, Kapten Muthoka, et al.
Gynecologic Oncology|February 2, 2010
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovaryTaymaa May, Carl Virtanen, Monika Sharma, et al.
Pageof 15

Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|April 15, 2008
Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1Ian Harley, Barry Rosen, Harvey A Risch, et al.
British Journal of Cancer|February 17, 2017
Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancerShana J Kim, Barry Rosen, Isabel Fan, et al.
Gynecologic Oncology|July 16, 2014
The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancerBarry Rosen, Stephane Laframboise, Sarah Ferguson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2Mario E Beiner, Barry Rosen, Anthony Fyles, et al.
Gynecologic Oncology|November 12, 2015
Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation statusJoanne Kotsopoulos, Barry Rosen, Isabel Fan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2014
Telomere length and mortality following a diagnosis of ovarian cancerJoanne Kotsopoulos, Jennifer Prescott, Immaculata De Vivo, et al.
Gynecologic Oncology|December 21, 2012
Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profilesTaymaa May, Melina Shoni, Christopher P Crum, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Role of adjuvant radiotherapy in granulosa cell tumors of the ovaryJan Hauspy, Mario E Beiner, Ian Harley, et al.
Ecancermedicalscience|October 18, 2024
'Addressing HPV vaccine hesitancy: unveiling concerns and building trust' perspectives of adolescent girls and parents in Kisumu County, KenyaEdwin Onyango Ochomo, Philiph Tonui, Kapten Muthoka, et al.
Gynecologic Oncology|February 2, 2010
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovaryTaymaa May, Carl Virtanen, Monika Sharma, et al.
Pageof 15